Literature DB >> 3415200

Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.

C L Joachim1, J H Morris, D J Selkoe.   

Abstract

One hundred fifty autopsy brains from patients with clinically diagnosed Alzheimer's disease (AD) were examined pathologically. The brains were received consecutively over a 3-year period from numerous sources as part of a research program in which one brain half was frozen for biochemical studies and the other half was fixed in formalin. One hundred thirty-one (87%) of the 150 cases fulfilled histological criteria for AD, with or without additional findings, such as Parkinson's disease or stroke. At least a minimal degree of amyloid angiopathy was found in every brain showing histopathological abnormalities of AD. Twenty-three (18%) of the 131 AD brains had Lewy bodies in neurons of the substantia nigra. Thirteen of the 19 non-AD cases were diagnosed as other neurodegenerative disorders. In only 2 cases was no histological correlate for the patient's dementia found. We conclude that (1) the many physicians who diagnosed these cases did so highly accurately; (2) degenerative changes in the substantia nigra were more common in patients with AD than has been reported for the general aged population; (3) amyloid angiopathy was a constant accompaniment of AD, although its severity varied widely; (4) vascular dementia was rarely clinically misdiagnosed as AD; (5) neuropathological findings were insufficient to account for the clinical syndrome of dementia in less than 2% of cases; (6) the histological criteria established by the National Institutes of Health/American Association of Retired Persons Workshop on the Diagnosis of Alzheimer's Disease worked well in assessing this large series.

Entities:  

Mesh:

Year:  1988        PMID: 3415200     DOI: 10.1002/ana.410240110

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  61 in total

Review 1.  Why should primary care physicians know about the genetics of dementia?

Authors:  L E Pinsky; W Burke; T D Bird
Journal:  West J Med       Date:  2001-12

Review 2.  Evolution of the diagnostic criteria for degenerative and cognitive disorders.

Authors:  Oscar L Lopez; Eric McDade; Mario Riverol; James T Becker
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

3.  Selective loss of nigral neurons in Alzheimer's disease: a morphometric study.

Authors:  T Uchihara; H Kondo; K Kosaka; H Tsukagoshi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Authors:  Thomas G Beach; Sarah E Monsell; Leslie E Phillips; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

5.  The genetics of Alzheimer disease--a teasing problem.

Authors:  J L Haines
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

6.  Segregation analysis reveals evidence of a major gene for Alzheimer disease.

Authors:  L A Farrer; R H Myers; L Connor; L A Cupples; J H Growdon
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

7.  The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease.

Authors:  M Kawai; R N Kalaria; S I Harik; G Perry
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

8.  Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys).

Authors:  Olivia M D'Angelo; Jeromy Dooyema; Cynthia Courtney; Lary C Walker; Eric Heuer
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

9.  Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset.

Authors:  Josephine Barnes; Bradford C Dickerson; Chris Frost; Lize C Jiskoot; David Wolk; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2015-04-24       Impact factor: 21.566

10.  Clinico-pathological correlation in dementias.

Authors:  F Teixeira; E Alonso; V Romero; A Ortíz; C Martínez; E Otero
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.